References
- Nielsen H E, Koch C, Mansa B, Magnussen P, Bergmann O J. Complement and immunoglobulin studies in 15 cases of chronic meningococcemia: Properdin deficiency and hypoimmunoglobulinemia. Scand J Infect Dis 1990; 22: 31–36
- The Meningococcal Disease Surveillance Group. Analysis of endemic meningococcal disease by serogroup and evaluation of chemoprophylaxis. J Infect Dis 1976; 134: 201–204
- Kronvall G. A rapid slide agglutination method for typing pneumococci by means of specific antibody adsorbed to protein A‐containing staphylococci. J Med Microbiol 1973; 6: 187–190
- Rønne T, Lind I, Buhl L H, Poolman J T, Zoffmann H. Recurrent localized outbreaks of group C meningococcal disease and selective vaccination programmes. J Microbiol 1986; 52: 221–222
- Riewerts Eriksen N H, Espersen F, Laursen L, Skinhøj P, Høiby N, Lind I. Nosocomial outbreak of group C meningococcal disease. Br Med J 1989; 298: 568–569
- Kolmos H J, Grytter C, Lind I. Meningococcal disease in two siblings – failure of rifampicin chemoprophylaxis. Ugeskr Læger 1987; 149: 3267–3268, (In Danish.)
- Kristensen K, Kaaber K, Rønne T, Olesen Larsen S, Henrichsen J. Epidemiology of Haemophilus influenzae type b infections among children in Denmark in 1985 and 1986. Acta Paediatr Scand 1990; 79: 587–592
- Cartwright K AV, Stuart J M, Noah N D. An outbreak of meningococcal disease in Gloucestershire. Lancet 1986; 2: 558–561
- Poolman J T, Lind I, Jónsdóttir K, Frøholm L O, Jones D M, Zanen H C. Meningococcal serotypes and serogroup B disease in North‐West Europe. Lancet 1986; 2: 555–558
- Weihe P, Mathiassen B, Rasmussen J M, Petersen T, Isager H. An epidemic outbreak of group B meningococcal disease on the Faroe Islands. Scand J Infect Dis 1988; 20: 291–296
- De Wals P, Hertoghe L, Borlée‐Grimée I, Heyne D, De Maeyer‐Cleempoel S, Reginster‐Haneuse G, Dachy A, Lechat M F. Meningococcal disease in Belgium. I. Risk of secondary cases among household contacts and evaluation of prophylaxis. Acta Paediatr Belgica 1978; 31: 73–78
- De Wals P, Hertoghe L, Borlée‐Grimée I, De Maeyer‐Cleempoel S, Reginster‐Haneuse G, Dachy A, Bouckaert A, Lechat M F. Meningococcal disease in Belgium. Secondary attack rate among household, daycare nursery and pre‐elementary school contacts. J Infect 1981; 3(Suppl 1)53–61
- Stuart J M, Cartwright K AV, Robinson P M, Noah N D. Does eradication of meningococcal carriage in household contacts prevent secondary cases of meningococcal disease?. Br Med J 1989; 298: 569–570
- Olcén P, Kjellander J, Danielsson D, Lindqvist B L. Epidemiology of Neisseria meningitidis: Prevalence and symptoms from the upper respiratory tract in family members to patients with meningococcal disease. Scand J Infect Dis 1981; 13: 105–109
- Jacobson J A, Camargos P AM, Ferreira J T, McCormick J B. The risk of meningitis among class‐room contacts during an epidemic of meningococcal disease. Am J Epidemiol 1976; 104: 552–555
- Artenstein M S, Ellis R E. The risk of exposure to a patient with meningococcal meningitis. Milit Med 1968; 133: 474–477
- Gaunt P N, Lambert B E. Single dose ciprofloxacin for the eradication of pharyngeal carriage of Neisseria meningitidis. J Antimicrob Chemother 1988; 21: 489–496
- Schwartz B, Al‐Tobaiqi A, Al‐Ruwais A, Fontaine R E, A'Ashi J, Hightower A W, Broome C V, Music S I. Comparative efficacy of ceftriaxone and rifampicin in eradicating pharyngeal carriage of group A Neisseria meningitidis. Lancet 1988; 1: 1239–1242
- Hassan‐King M KA, Wall R A, Greenwood B M. Meningococcal carriage, meningococcal disease and vaccination. J Infect 1988; 16: 55–59
- Poolman J T. Meningococcal vaccines. J Med Microbiol 1988; 26: 170–172